Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Diabetes and depression

  • Jeon, Eon-Ju (Department of Internal Medicine, Catholic University of Daegu, School of Medicine)
  • Received : 2018.04.22
  • Accepted : 2018.06.08
  • Published : 2018.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Diabetes and depression are serious chronic conditions. As a result of their increasing prevalence, diabetes and depression, together with population growth and aging, are public health issues. The rate of depression in adults with either type 1 diabetes or type 2 diabetes is high relative to the general population. The coexistence of diabetes and depression has attracted much interest. Although it is unclear whether diabetes and depression are causally linked, most studies have shown that the association between diabetes and depression might be bidirectional. Currently, emotional well-being is becoming an increasingly important aspect of diabetes care and self-management. Psychiatric disorders and diabetic distress among people with diabetes may increase the risk of diabetes complication and mortality. Thus, assessment and appropriate management of depression in people with diabetes should be considered to achieve psychological well-being and optimize medical outcomes.

Keywords

References

  1. International Diabetes Federation. IDF diabetes atlas. 8th ed. Brussels: International Diabetes Federation; 2017.
  2. World Health Organization. Depression and other common. mental disorders: global health estimates. Geneva: World Health Organization; 2017.
  3. Korean Diabetes Association. Diabetes fact sheet in Korea 2016 [Internet]. Seoul: Korean Diabetes Association; 2017 [cited 2018 April 18]. http://www.diabetes.or.kr/temp/KDA_fact_sheet%202016.pdf
  4. TabAk AG, Akbaraly TN, Batty GD, KivimAki M. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol 2014;2:236-45. https://doi.org/10.1016/S2213-8587(13)70139-6
  5. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med 2008;121(11 Suppl 2):S8-15. https://doi.org/10.1016/j.amjmed.2008.09.008
  6. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006;23:579-93. https://doi.org/10.1111/j.1464-5491.2006.01918.x
  7. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington: American Psychiatric Association; 2010.
  8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Ekoe JM, Punthakee Z, Ransom T, Prebtani AP, Goldenberg R. Screening for type 1 and type 2 diabetes. Can J Diabetes 2013;37(Suppl 1):S12-5.
  9. Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016;39:2126-40. https://doi.org/10.2337/dc16-2053
  10. Kahn CR, Weir GC, King GL, Moses AC, Smith RJ, Jacobson AM. Joslin's diabetes mellitus. 14th ed. Philadelphia: Lippincott Williams & Willkins; 2005.
  11. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH. Evidence for diabetic encephalopathy. Diabet Med 1991;8:162-7. https://doi.org/10.1111/j.1464-5491.1991.tb01564.x
  12. Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model - are we there yet? Behav Brain Res 2018;341:79-90. https://doi.org/10.1016/j.bbr.2017.12.025
  13. Nagy G, Ronai Z, Somogyi A, Sasvari-Szekely M, Rahman OA, Mate A, et al. P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1884-8. https://doi.org/10.1016/j.pnpbp.2008.08.021
  14. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol 2015;3:461-71. https://doi.org/10.1016/S2213-8587(15)00134-5
  15. World Health Organization. Pharmacological treatment of mental disorders in primary health care. Geneva: World Health Organization; 2009.
  16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington: American Psychiatric Association; 2013.
  17. Willis T. Diabetes; a medical odyssey. Tuckahoe: USV Pharmaceutical Corp.; 1971.
  18. Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev 2011;31:1239-46. https://doi.org/10.1016/j.cpr.2011.08.001
  19. Grey M, Cameron ME, Lipman TH, Thurber FW. Psychosocial status of children with diabetes in the first 2 years after diagnosis. Diabetes Care 1995;18:1330-6. https://doi.org/10.2337/diacare.18.10.1330
  20. Winkley K, Ismail K, Landau S, Eisler I. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006;333:65. https://doi.org/10.1136/bmj.38874.652569.55
  21. Bennett DS. Depression among children with chronic medical problems: a meta-analysis. J Pediatr Psychol 1994;19:149-69. https://doi.org/10.1093/jpepsy/19.2.149
  22. Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CH. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav 2015;9:651-62. https://doi.org/10.1007/s11682-014-9348-2
  23. Korczak DJ, Pereira S, Koulajian K, Matejcek A, Giacca A. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia 2011;54:2483-93. https://doi.org/10.1007/s00125-011-2240-3
  24. Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, et al. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry 2009;66:878-87. https://doi.org/10.1001/archgenpsychiatry.2009.86
  25. Lyoo IK, Yoon S, Jacobson AM, Hwang J, Musen G, Kim JE, et al. Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression. Arch Gen Psychiatry 2012;69:1267-76. https://doi.org/10.1001/archgenpsychiatry.2012.543
  26. Bolo NR, Musen G, Simonson DC, Nickerson LD, Flores VL, Siracusa T, et al. Functional connectivity of insula, basal ganglia, and prefrontal executive control networks during hypoglycemia in type 1 diabetes. J Neurosci 2015;35:11012-23. https://doi.org/10.1523/JNEUROSCI.0319-15.2015
  27. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care 1988;11:605-12.
  28. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996;19:1097-102. https://doi.org/10.2337/diacare.19.10.1097
  29. Lee HS, Lee JS, Lee HP, Jeon CE. Diabetes, Depression and doctor-patient relationship. Korean Diabetes J 2009;33:178-82. Korean. https://doi.org/10.4093/kdj.2009.33.3.178
  30. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902. https://doi.org/10.1038/nature07455
  31. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus:a meta-analysis. Diabetologia 2006;49:837-45. https://doi.org/10.1007/s00125-006-0159-x
  32. Maes M. Cytokines in major depression. Biol Psychiatry 1994;36:498-9.
  33. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-23. https://doi.org/10.2337/diacare.27.3.813
  34. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol 2008;23:571-85. https://doi.org/10.1002/hup.964
  35. Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 2014;1311:151-73. https://doi.org/10.1111/nyas.12355
  36. Kan C, Pedersen NL, Christensen K, Bornstein SR, Licinio J, MacCabe JH, et al. Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries. Mol Psychiatry 2016;21:903-9. https://doi.org/10.1038/mp.2016.28
  37. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78. https://doi.org/10.2337/diacare.24.6.1069
  38. Beck AT, Steer RA, Brown GK. BDI-II, beck depression inventory: manual. 2nd ed. San Antonio: Psychological Corp.; Boston: Harcourt Brace; 1996.
  39. Zauszniewski JA, Chung C, Krafcik K, Sousa VD. Psychometric testing of the depressive cognition scale in women with type 2 diabetes. J Nurs Meas 2001;9:61-72.
  40. Colon de Marti LN, Guzman Yunque FS, Guevara-Ramos LM. Early detection of depression using the Zung Self-Rating Depression Scale. P R Health Sci J 1997;16:375-9.
  41. Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 2001;24:1751-7. https://doi.org/10.2337/diacare.24.10.1751
  42. Marathe PH, Gao HX, Close KL. American Diabetes Association Standards of Medical Care in Diabetes 2017. J Diabetes 2017;9:320-4. https://doi.org/10.1111/1753-0407.12524
  43. Jones A, Vallis M, Pouwer F. If it does not significantly change HbA1c levels why should we waste time on it? A plea for the prioritization of psychological well-being in people with diabetes. Diabet Med 2015;32:155-63. https://doi.org/10.1111/dme.12620
  44. Deborah YH, Mark P. Psychosocial care for people with diabetes. Alexandria: American Diabetes Association; 2012. p. 240.
  45. Lim SY, Lee EJ, Jeong SW, Kim HC, Jeong CH, Jeon TY, et al. The validation study of Beck Depression Scale 2 in Korean version. Anxiety Mood 2011;7:48-53.
  46. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-56. https://doi.org/10.1001/jama.1994.03520220043029
  47. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002;32:509-15. https://doi.org/10.3928/0048-5713-20020901-06
  48. Shin JH, Kim HC, Jung CH, Kim JB, Jung SW, Cho HJ, et al. The Standardization of the Korean Version of the Patient Health Questionnaire-2. J Korean Neuropsychiatr Assoc 2013;52:115-21. Korean. https://doi.org/10.4306/jknpa.2013.52.3.115
  49. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71. https://doi.org/10.1001/archpsyc.1961.01710120031004
  50. Yoon SY, Lim JH, Han C. Rating scales for measurementbased clinical practice of depression. Korean J Psychopharmacol 2012;23:136-46. Korean.
  51. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49.
  52. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, editor. Clinical gerontology: a guide to assessment and intervention. New York: The Haworth Press; 1986. p. 165-73.
  53. Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res 2004;57:297-305. https://doi.org/10.1016/j.jpsychores.2004.01.004
  54. Montorio I, Izal M. The Geriatric Depression Scale: a review of its development and utility. Int Psychogeriatr 1996;8:103-12.
  55. World Health Organization. ICD-10 Version: 2016 [Internet]. Geneva: World Health Organization; 2017 [cited 2018 April 18]. http://apps.who.int/classifications/icd10/browse/2016/en
  56. Kwon JS, Kee NK, Bahk WM, Shin MS, Yu BH, YoonJS, et al. Diagnostic and statistical manual of mental disorders DSM. 5th ed. Seoul: Hakjisa; 2015.
  57. Saito M, Iwata N, Kawakami N, Matsuyama Y, Ono Y, Nakane Y, et al. Evaluation of the DSM-IV and ICD-10 criteria for depressive disorders in a community population in Japan using item response theory. Int J Methods Psychiatr Res 2010;19:211-22. https://doi.org/10.1002/mpr.320
  58. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934-42. https://doi.org/10.2337/diacare.23.7.934
  59. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007;30:2222-7. https://doi.org/10.2337/dc07-0158
  60. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008;31:2398-403. https://doi.org/10.2337/dc08-1341
  61. Park HS, Hong YS, Lee HJ, Ha EH, Sung YA. The association between depressive symptoms and glycemic control in the patients with diabetes mellitus. Korean J Med 2003;64:204-10. Korean.
  62. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619-30. https://doi.org/10.1097/00006842-200107000-00015
  63. Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010;33:264-9. https://doi.org/10.2337/dc09-1068
  64. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005;28:1339-45. https://doi.org/10.2337/diacare.28.6.1339
  65. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005;161:652-60. https://doi.org/10.1093/aje/kwi089
  66. Kovacs M. Children's depression inventory (CDI2): technical manual. North Tonawanda: Multi-Health Systems; 2011.

Cited by

  1. Habenula lesions improve glucose metabolism in rats with type 2 diabetes by increasing insulin sensitivity and inhibiting gluconeogenesis vol.8, pp.1, 2018, https://doi.org/10.1136/bmjdrc-2020-001250
  2. Bioinformatics and Network Pharmacology-Based Approaches to Explore the Potential Mechanism of the Antidepressant Effect of Cyperi Rhizoma through Soothing the Liver vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/8614963